betaxolol has been researched along with Day Blindness in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four hundred sixteen subjects with ocular hypertension (intraocular pressure >/=22 and | 2.75 | The ability of short-wavelength automated perimetry to predict conversion to glaucoma. ( Colen, TP; Lemij, HG; Reus, NJ; van der Schoot, J, 2010) |
| "Patients with primary open angle glaucoma (N = 16) were retrospectively evaluated to determine changes in visual function, as measured by contrast sensitivity, after beta-blocker therapy." | 1.29 | Test-retest reliability of the CSV-1000 contrast test and its relationship to glaucoma therapy. ( Evans, DW; Pomerance, GN, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, K | 1 |
| Brock-Utne, JG | 1 |
| Öhnell, H | 1 |
| Heijl, A | 5 |
| Brenner, L | 1 |
| Anderson, H | 1 |
| Bengtsson, B | 6 |
| van der Schoot, J | 1 |
| Reus, NJ | 1 |
| Colen, TP | 1 |
| Lemij, HG | 1 |
| Leske, MC | 4 |
| Hyman, L | 3 |
| Yang, Z | 1 |
| Cho, HK | 1 |
| Kee, C | 1 |
| Hussein, M | 1 |
| Pomerance, GN | 1 |
| Evans, DW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression - A Randomized Control Trial[NCT05940623] | 142 participants (Anticipated) | Interventional | 2023-08-24 | Not yet recruiting | |||
| Effect of Medically Lowering Intraocular Pressure in Glaucoma Suspects With High Myopia: A Randomized Controlled Trial[NCT04296916] | 264 participants (Anticipated) | Interventional | 2020-04-17 | Recruiting | |||
| Effect of Medically Intraocular Pressure Lowering on Progressive High Myopia[NCT05850936] | 152 participants (Anticipated) | Interventional | 2023-06-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for betaxolol and Day Blindness
| Article | Year |
|---|---|
Structural and Functional Progression in the Early Manifest Glaucoma Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Betaxolol; Combined Modality Therapy; Diagnostic Techn | 2016 |
The ability of short-wavelength automated perimetry to predict conversion to glaucoma.
Topics: Aged; Antihypertensive Agents; Betaxolol; Double-Blind Method; Female; Follow-Up Studies; Glaucoma; | 2010 |
Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
Topics: Aged; Antihypertensive Agents; Betaxolol; Combined Modality Therapy; Disease Progression; Female; Gl | 2011 |
Measuring visual field progression in the Early Manifest Glaucoma Trial.
Topics: Aged; Antihypertensive Agents; Betaxolol; Disease Progression; Glaucoma, Open-Angle; Humans; Intraoc | 2003 |
Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Betaxolol; Combined Modality Therapy; Disease Prog | 2007 |
Early Manifest Glaucoma Trial: design and baseline data.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Disease Progression; Female; Glauco | 1999 |
Early Manifest Glaucoma Trial: design and baseline data.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Disease Progression; Female; Glauco | 1999 |
Early Manifest Glaucoma Trial: design and baseline data.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Disease Progression; Female; Glauco | 1999 |
Early Manifest Glaucoma Trial: design and baseline data.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Disease Progression; Female; Glauco | 1999 |
3 other studies available for betaxolol and Day Blindness
| Article | Year |
|---|---|
Can preoperative betaxolol eye drops reduce the incidence of postoperative visual loss (POVL)?
Topics: Adrenergic beta-Antagonists; Betaxolol; Humans; Intraocular Pressure; Middle Aged; Ophthalmic Soluti | 2014 |
Comparison of the progression rates of the superior, inferior, and both hemifield defects in normal-tension glaucoma patients.
Topics: Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Cohort Studies; Disease Progression; Femal | 2012 |
Test-retest reliability of the CSV-1000 contrast test and its relationship to glaucoma therapy.
Topics: Aged; Betaxolol; Contrast Sensitivity; Glaucoma, Open-Angle; Humans; Levobunolol; Middle Aged; Repro | 1994 |